Klampfl
Erica Z. Klampfl, Canton, MI US
Patent application number | Description | Published |
---|---|---|
20130232027 | Fleet Purchase Planner - A system and method for generating a vehicle fleet configuration for purchase, replacement, and/or deployment of vehicles include an input device configured to receive user input indicative of a number of vehicles to purchase and at least one fleet operational parameter target. A computer in communication with the input device and a database having emissions and fuel economy information for a plurality of available vehicle models and associated powertrain configurations is configured to generate a recommended number of vehicles for each of the available vehicle models with associated powertrain configurations to satisfy the number of vehicles to purchase, wherein the operational parameters associated with the number of vehicles satisfy at least one fleet operational parameter target, which may include one of minimizing cost or minimizing emissions, for example. | 09-05-2013 |
Heinz Karl Klampfl, Barnbach AT
Patent application number | Description | Published |
---|---|---|
20140205369 | JOINT DESIGN WELDING DISSIMILAR MATERIALS - A joint site design for welding of a shaft has a tubular shape composed of a hard material with a hub having a flat shape composed of softer material. The shaft is joined by welding at a connection area located at an end face thereof to a connection area of the hub located at a radial shoulder thereof. | 07-24-2014 |
Thorsten Klampfl, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20150079091 | MUTANT CALRETICULIN FOR THE DIAGNOSIS OF MYELOID MALIGNANCIES - Mutations in calreticulin are discovered to be linked to myeloid malignancies. Disclosed are genomic sequences, cDNA sequences, mRNA sequences and protein sequences of mutant calreticulin that are linked to myeloid malignancies. Also disclosed are methods for diagnosing myeloid malignancy comprising determining the presence of a mutant allele of the calreticulin gene. Also disclosed are related compositions, kits and methods, including the medical use of inhibitors of mutant calreticulin. | 03-19-2015 |